JPH02121966A - インドール誘導体およびそれを有効成分として含有する制癌剤効果増強剤 - Google Patents

インドール誘導体およびそれを有効成分として含有する制癌剤効果増強剤

Info

Publication number
JPH02121966A
JPH02121966A JP27445188A JP27445188A JPH02121966A JP H02121966 A JPH02121966 A JP H02121966A JP 27445188 A JP27445188 A JP 27445188A JP 27445188 A JP27445188 A JP 27445188A JP H02121966 A JPH02121966 A JP H02121966A
Authority
JP
Japan
Prior art keywords
formula
compound
group
anticancer drug
compound expressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP27445188A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0565507B2 (enExample
Inventor
Nobuyuki Fukazawa
深澤　信幸
Makoto Odate
尾舘　誠
Tsuneshi Suzuki
常司 鈴木
Takashi Tsuruo
隆 鶴尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japanese Foundation for Cancer Research
Mitsui Toatsu Chemicals Inc
Original Assignee
Japanese Foundation for Cancer Research
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japanese Foundation for Cancer Research, Mitsui Toatsu Chemicals Inc filed Critical Japanese Foundation for Cancer Research
Priority to JP27445188A priority Critical patent/JPH02121966A/ja
Publication of JPH02121966A publication Critical patent/JPH02121966A/ja
Publication of JPH0565507B2 publication Critical patent/JPH0565507B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
JP27445188A 1988-11-01 1988-11-01 インドール誘導体およびそれを有効成分として含有する制癌剤効果増強剤 Granted JPH02121966A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27445188A JPH02121966A (ja) 1988-11-01 1988-11-01 インドール誘導体およびそれを有効成分として含有する制癌剤効果増強剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27445188A JPH02121966A (ja) 1988-11-01 1988-11-01 インドール誘導体およびそれを有効成分として含有する制癌剤効果増強剤

Publications (2)

Publication Number Publication Date
JPH02121966A true JPH02121966A (ja) 1990-05-09
JPH0565507B2 JPH0565507B2 (enExample) 1993-09-17

Family

ID=17541875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27445188A Granted JPH02121966A (ja) 1988-11-01 1988-11-01 インドール誘導体およびそれを有効成分として含有する制癌剤効果増強剤

Country Status (1)

Country Link
JP (1) JPH02121966A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130217A (en) * 1995-09-20 2000-10-10 Pfizer Inc Compounds enhancing antitumor activity of other cytotoxic agents

Also Published As

Publication number Publication date
JPH0565507B2 (enExample) 1993-09-17

Similar Documents

Publication Publication Date Title
TWI804933B (zh) 用作cdk7激酶抑制劑的化合物及其應用
CN108884101B (zh) 取代的吡咯并嘧啶类cdk抑制剂、包含其的药物组合物以及它们的用途
WO2012089106A1 (zh) 作为蛋白激酶抑制剂的芳炔类衍生物及其医疗用途
EP3939981B1 (en) Fused thiazolopyrimidine derivatives as mnks inhibitors
WO2023088385A1 (zh) 用于egfr蛋白降解的化合物及其用途
CN102911118B (zh) 一类苯并氮杂卓类衍生物及其制备方法和用途
JP3076672B2 (ja) キノリン誘導体のフマル酸塩
JPH02121966A (ja) インドール誘導体およびそれを有効成分として含有する制癌剤効果増強剤
CN105693729B (zh) 吲哚并 [ 3 , 2 ‑ a ] 咔唑衍生物及其应用
CN108101889A (zh) 氘代n-[5-(嘧啶-2-氨基)-2,4-二取代苯基]-反式-2,4-戊二烯酰胺
CN114276333A (zh) 二氢喹喔啉类溴结构域二价抑制剂
CN110407839A (zh) 含杂芳基酰胺结构的三唑并杂环类化合物的制备及应用
CN110467616A (zh) 含杂芳基取代哒嗪酮结构的三唑并吡嗪类化合物的制备及应用
CN106083702B (zh) 吡非尼酮衍生物及其制备方法
CN118355000A (zh) 二甲基亚磺酰亚胺衍生物的盐型及晶型
JPH04356466A (ja) 新規キノリン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
JPH02121924A (ja) 制癌剤効果増強剤
WO2022127904A1 (zh) 一种吲唑类衍生物的药学上可接受的盐、结晶形式及其制备方法
JP2781073B2 (ja) 新規キノリン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
CN103214486A (zh) β-咔啉衍生物或可药用盐，其制备方法及其抗肿瘤的应用
CN106083817B (zh) 吡非尼酮衍生物及其制备方法
CN103936735B (zh) 氮杂苯并薁衍生物及其制备方法和用途
CN103172578A (zh) 4-环末端取代2-1,2,3-三氮唑苯胺类化合物的制备和用途
CN103159748B (zh) 2-(1h-1，2，3-三氮唑-4-基)苯胺类化合物的制备和用途
WO2023006057A1 (zh) 氨基吡唑并嘧啶化合物的晶体

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080917

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080917

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090917

Year of fee payment: 16

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090917

Year of fee payment: 16